Director Kathy Hibbs sells SOPHiA GENETICS (SOPH) shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
SOPHiA GENETICS SA director Kathy L. Hibbs reported an open-market sale of 7,508 Ordinary Shares on May 12, 2026. The shares were sold at a weighted average price of $4.6666 per share, in multiple trades between $4.54 and $4.85.
The transaction was made pursuant to a duly adopted trading plan under Rule 10b5-1(c). Following this sale, Hibbs directly owns 89,768 Ordinary Shares. This represents a partial reduction of her holdings while retaining a substantial remaining position in the company.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 7,508 shares ($35,037)
Net Sell
1 txn
Insider
HIBBS KATHY L
Role
null
Sold
7,508 shs ($35K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 7,508 | $4.6666 | $35K |
Holdings After Transaction:
Ordinary Shares — 89,768 shares (Direct, null)
Footnotes (1)
- Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 7,508 shares
Weighted average sale price: $4.6666 per share
Price range of sales: $4.54–$4.85 per share
+1 more
4 metrics
Shares sold
7,508 shares
Open-market sale on May 12, 2026
Weighted average sale price
$4.6666 per share
Ordinary Shares sold in multiple transactions
Price range of sales
$4.54–$4.85 per share
Range of individual trade prices for this transaction
Shares owned after transaction
89,768 shares
Direct ownership by Kathy L. Hibbs after sale
Key Terms
Rule 10b5-1(c), weighted average price, open-market sale, Ordinary Shares
4 terms
Rule 10b5-1(c) regulatory
"Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c)."
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What insider transaction did SOPHiA GENETICS (SOPH) report for Kathy L. Hibbs?
SOPHiA GENETICS reported that director Kathy L. Hibbs sold 7,508 Ordinary Shares in an open-market transaction. The sale occurred on May 12, 2026, and was executed under a Rule 10b5-1(c) trading plan, indicating it was pre-arranged rather than discretionary.
Was the SOPHiA GENETICS (SOPH) insider sale by Kathy L. Hibbs under a 10b5-1 plan?
Yes. The filing states the transaction was made under a duly adopted trading plan pursuant to Rule 10b5-1(c). Such plans are established in advance, aiming to systematize trades and reduce concerns that timing decisions reflect undisclosed company information.
What does the weighted average price mean in the SOPHiA GENETICS (SOPH) Form 4?
The weighted average price of $4.6666 reflects multiple sale transactions combined into a single average figure. Actual trades ranged from $4.54 to $4.85 per share, and the reporting person has committed to provide the exact share counts at each price upon written request.